Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men study

Norman, Paul E., Davis, Wendy A., Coughlan, Melinda T., Forbes, Josephine M., Golledge, Jonathan and Davis, Timothy M. E. (2009) Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men study. Journal of Vascular Surgery, 50 3: 626-631. doi:10.1016/j.jvs.2009.05.058


Author Norman, Paul E.
Davis, Wendy A.
Coughlan, Melinda T.
Forbes, Josephine M.
Golledge, Jonathan
Davis, Timothy M. E.
Title Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men study
Journal name Journal of Vascular Surgery   Check publisher's open access policy
ISSN 0741-5214
1097-6809
Publication date 2009-09
Sub-type Article (original research)
DOI 10.1016/j.jvs.2009.05.058
Open Access Status
Volume 50
Issue 3
Start page 626
End page 631
Total pages 6
Place of publication Philadelphia, PA, United States
Publisher Mosby
Language eng
Formatted abstract
Objective: Abdominal aortic aneurysms (AAAs) share common risk factors with atherosclerosis, except for diabetes which appears protective. The reason for this is unknown. Although increased circulating concentrations of advanced glycation endproducts (AGEs) such as carboxymethyllysine (CML) are associated with occlusive vascular disease, it is possible that their effects on the aortic wall explain the paradoxically low incidence of AAAs in diabetes.
Methods: We studied 234 community-dwelling men aged 65 to 79 years. The cases comprised all identifiable diabetic men with AAA (aortic diameter ≥30 mm on ultrasound; n = 27) and randomly-selected non-diabetic men with AAA (n = 67). Controls were age-matched randomly-selected diabetic men (n = 69) and age-matched randomly-selected non-diabetic men (n = 71) without AAA (aortic diameter 18 to 22 mm). Serum CML concentrations were measured by validated indirect enzyme-linked immunosorbent assay (ELISA).
Results: Serum CML concentrations were significantly lower in men with AAAs than those without (6627 ± 1544 vs 7309 ± 1490 nmol/mol lysine; P = .001). Variables positively associated with AAA were height, diastolic blood pressure, smoking, a history of coronary heart disease, and serum creatinine (P ≤ .040), while serum CML (odds ratio [95% confidence interval] per 1000 nmol/mol lysine; 0.80 [0.64-0.98]) and a history of diabetes were inversely associated (P ≤ .040). After adjusting, the interaction between diabetes status and serum CML was negatively associated with AAA (P = .016).
Conclusion: These cross-sectional data show that circulating concentrations of CML are reduced in diabetic men with AAAs. This is in contrast to studies of the relationship between AGEs and occlusive manifestations of cardiovascular disease and could explain the inverse association between diabetes and AAA.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Mater Research Institute-UQ (MRI-UQ)
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 9 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 9 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Mon, 15 Dec 2014, 10:49:50 EST by System User on behalf of Mater Research Institute-UQ